Project Number 16 05 Agency/Funding Organization Alzheimer Society of Canada Funding Year 2015 View Full Project Details for MicroRNA-132 replacement therapy for Alzheimer’s disease in a mouse model Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 1. Research Resources and Enabling Technologies to Accelerate Therapy Development a. Enabling Technologies Researcher and Organization Principal Investigator Hébért, Sebastien Principal Investigator First Name Sebastien Principal Investigator Last Name Hébért Awardee Organization Université Laval Contact PI Country Canada Project Detail FY Overall Cost $150,000 Funding Organization Agency/Funding Organization Alzheimer Society of Canada Funding Organization Country Canada
